Search
Milestone Pharmaceuticals Inc
MISTAdd to Watchlist
0.801USD
-0.061-7.08%
Market hours 09/24, 13:36（ET）
99.72MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-7.08%
5 Days
-9.90%
1 Month
-24.08%
6 Months
-36.43%
Year to Date
-60.35%
1 Year
-58.50%
Key Figures
0.870Open
0.925High
67.80KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.05%Turnover Ratio
0.862Prev. Close
0.790Low
55.37KTurnover
LossP/E Static
5.47P/B
0.00%Div Yield TTM
-53.49%ROA
3.06052wk High
0.10Volume Ratio
-41.52MNet Profit
124.50MShares
-0.6386EPS TTM
0.98Beta
-456.88%ROE
0.79052wk Low
15.66%Amplitude
94.28%Gross Margin
99.72MMarket Cap
-1.56Reward/Risk
4.55%Risk Rate
Milestone Pharmaceuticals Inc's Score
-0.01vs previous score
Forecast8.00
Financial Health5.84
Technical4.94
Valuation Dimensions6.31
Institutional Confidence3.00
Risk Assessment3.38
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Milestone Pharmaceuticals Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Strong sell
Moving Average
Strong sell
Milestone Pharmaceuticals Inc Latest Earnings Call Transcripts
Milestone Pharmaceuticals (MIST) Q2 2026 Earnings Call: CARDAMYST Coverage Tops 50%
Milestone Pharmaceuticals' Q2 2026 earnings call covered $0.6 million in CARDAMYST revenue, coverage above 50%, launch spending and the ReVeRA-301 trial.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.21/-0.20
Revenue / Forecast
559.00K/816.67K
Milestone Pharmaceuticals Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolMIST
Number of employees33
CountryCanada
Ownership
| Shareholders | Proportion |
|---|---|
| Simplify Asset Management Inc | 4.70% |
| Propel Bio Management, LLC | 4.28% |
| Adage Capital Management, L.P. | 2.35% |
| Oliveto (Joseph Gerard) | 2.18% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 7.06% |
| Hedge Fund | 6.74% |
| Investment Advisor/Hedge Fund | 4.75% |
| Venture Capital | 4.43% |
Related Instruments
+3.35%
+0.75%
-0.36%
+0.30%
+0.46%
+1.34%
-0.25%
-0.34%
+0.30%
+1.06%
+0.96%
-0.35%
-0.06%
+0.01%
-1.67%
-1.09%
+0.76%
+0.95%
-1.28%
+1.78%Popular Instruments
51292.400
-197.600 (-0.38%)
30423.600
-54.300 (-0.18%)
7699.000
-8.000 (-0.10%)
14269.000
-153.000 (-1.06%)
65788.000
-341.000 (-0.52%)
6306.200
+16.200 (+0.26%)
94.953
+2.463 (+2.66%)
337.260
+0.240 (+0.07%)
223.890
-1.620 (-0.72%)
4262.460
-23.780 (-0.56%)
FAQs
What is the current price of Milestone Pharmaceuticals Inc (MIST)?
The current price of Milestone Pharmaceuticals Inc (MIST) is 0.86.
What is the symbol of Milestone Pharmaceuticals Inc?
The ticker symbol of Milestone Pharmaceuticals Inc is MIST.
What is the 52-week high of Milestone Pharmaceuticals Inc?
The 52-week high of Milestone Pharmaceuticals Inc is 3.06.
What is the 52-week low of Milestone Pharmaceuticals Inc?
The 52-week low of Milestone Pharmaceuticals Inc is 0.85.
What is the market capitalization of Milestone Pharmaceuticals Inc?
The market capitalization of Milestone Pharmaceuticals Inc is 107.32M.
Is Milestone Pharmaceuticals Inc (MIST) currently rated as Buy, Hold, or Sell?
According to analysts, Milestone Pharmaceuticals Inc (MIST) has an overall rating of Buy, with a price target of 5.86.
What is the Earnings Per Share (EPS TTM) of Milestone Pharmaceuticals Inc (MIST)?
The Earnings Per Share (EPS TTM) of Milestone Pharmaceuticals Inc (MIST) is -0.64.